Osteogenesis Imperfecta Type III: Clinical Trials

2 trials for Osteogenesis Imperfecta Type III, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow Osteogenesis Imperfecta Type III: new trials by email Literature Review of Osteogenesis Imperfecta Type III trials Research Report on Osteogenesis Imperfecta Type III

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI)
Bone marrow-derived mesenchymal stromal cells (MSCs) - Osteogenesis Imperfecta, Osteogenesis Imperfecta Type III
Phase 1 / Phase 2Not yet recruitingEmory University122027-01-012026-05-08
Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta
Mesenchymal Stromal Cells - Osteogenesis Imperfecta Type II, Osteogenesis Imperfecta Type III
Phase 1CompletedNationwide Children's Hospital52010-02-012015-04-24

Narrower conditions

Osteogenesis Imperfecta (2)  ·  Osteogenesis imperfecta, type 3 (2)

Broader conditions

Bone Diseases (2)  ·  Bone Diseases, Developmental (2)  ·  Collagen Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Connective Tissue Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Musculoskeletal Diseases (2)  ·  Osteochondrodysplasias (2)  ·  Skin and Connective Tissue Diseases (2)

Sponsors

Emory University (1)  ·  Nationwide Children's Hospital (1)

Countries

United States (1)

Top investigators

Alix Seif, MD (1)  ·  Doris Fadoju, MD (1)